Skip to content
Screener

Exelixis EXEL PP&E (Net)

PP&E (Net) at other companies

Eli Lilly logo
Eli LillyLLY
$29.29B+42.7%
Pfizer logo
PfizerPFE
$19.4B+5.8%
Kura Oncology logo
Kura OncologyKURA
$7.61M+224%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$6.38M-15.4%
Immunome logo
ImmunomeIMNM
$17.08M+55.9%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$36M-18.2%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$12.93B+27.4%
Enterprise value$12.82B+26.1%
P/E15×-1.8×
P/S5.3×+0.8×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemJune 30, 2026December 31, 2025
Prepaid expenses and other current assets60,49575,596
Total current assets1,250,8221,443,289
Non-current marketable securities544,930603,603
Property and equipment, net92,66598,960
Deferred tax assets, net294,205292,582
Goodwill63,68463,684
Right-of-use assets and other non-current assets247,928342,305
Total assets$2,494,234$2,844,423

Item 1. Financial Statements.

FAQ

What is Exelixis's PP&E (net)?
Exelixis (EXEL) reported PP&E (net) of $92.67M in Q2 2026.
How has Exelixis's PP&E (net) changed year-over-year?
Exelixis's PP&E (net) decreased by 16.0% year-over-year, from $110.31M to $92.67M.
What is the long-term trend for Exelixis's PP&E (net)?
Over 5 years (2020 to 2025), Exelixis's PP&E (net) has grown at a 8.0% compound annual growth rate (CAGR), from $67.38M to $98.96M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Exelixis's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude